Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia

NCT01810939 is registered in ClinicalTrials.gov with Relypsa, Inc. as lead sponsor.

NCT NCT01810939
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01810939 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia
Lead sponsor
Relypsa, Inc.
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2013
Completion date
August 31, 2013
Enrollment
243 (actual)
Sites
58

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease (ckd), hyperkalemia (hk)